September 19, 2025Annals of HematologyOpen Access

T-cell acute lymphoblastic leukemia: therapeutic outcomes in adolescents and young adults

View Full Paper

Ask AI

Bookmark

Authors

Discussion

This study evaluates survival rates and therapy outcomes for T-ALL in adolescents and young adults, suggesting the need for enhanced risk management.

Complete remission was achieved in 84.4% of cases, indicating effective treatment response in AYA patients.
Five-year overall survival and event-free survival rates were 62.2% and 62.5%, highlighting the need for improved therapies.
Patients showed better outcomes when reaching MRD negativity, suggesting its importance in treatment planning.
High relapse rates and 9.4% induction mortality indicate that further strategies are essential to improve long-term prognoses.

Azza et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This study evaluates survival rates and therapy outcomes for T-ALL in adolescents and young adults, suggesting the need for enhanced risk management.